The tumor microenvironment (TME) is critical in the progression and metastasis of skin cutaneous melanoma (SKCM).
Publications
Metastatic melanoma concurrent to the urinary bladder and endometrium: Case report
We report a case of a 47-year-old woman with a history of acral lentiginous melanoma, left great toe subungual primary, metastatic to the lungs, brain, and spleen, presenting with lower urinary tract symptoms.
FDA Approves Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma Following CR
The FDA has approved pembrolizumab (Keytruda) for the adjuvant treatment of adult and pediatric patients with stage IIB or IIC melanoma following complete resection (CR).
FDA approves adjuvant Keytruda for certain adults, children with stage IIB, IIC melanoma
The FDA approved pembrolizumab as adjuvant therapy for adults and children aged 12 years or older with stage IIB or IIC melanoma after complete resection.